We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis

This study has been terminated.
(Stopped due to futility.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01038739
First Posted: December 24, 2009
Last Update Posted: July 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH